FDA warns after 30+ people got sick from a trendy anti-aging IV drip

The US Food and Drug Administration (FDA) has warned pharmacies to stop using supplement-grade glutathione, a popular “detox” and anti-aging product, to make IV drips. The agency said it knew of at least 30 people who became ill after receiving glutathione by IV, some of whom needed a hospital.¹ The notice is dated August 27, 2026.¹ Since then, more pharmacies have recalled products and the US Centers for Disease Control and Prevention (CDC) has opened its own investigation.²

Glutathione has been nicknamed the “master detoxifier” and has become a trendy longevity supplement, taken both by mouth and by IV drip.³

What happened

According to the FDA, the people who fell ill received IV glutathione, either alone or mixed with other ingredients.¹ Reported problems included fever, chills, pain, dizziness, signs of shock and sepsis-like symptoms, with some people hospitalized.¹ Sepsis is a dangerous body-wide reaction, and “sepsis-like” means the symptoms looked similar.

The drips were made by different compounding pharmacies.¹ Compounded drugs are medicines that a pharmacist or doctor mixes or changes to fit a person’s needs, rather than products made in a drug factory.³ The FDA said all of the pharmacies got their glutathione from the same batch, lot #229536, sold by Medisca Inc., whose US headquarters is in Plattsburgh, New York.¹ That glutathione was labeled as dietary supplement grade, which the FDA said “is not an appropriate ingredient to make injectable drugs.”¹

Medisca told the FDA on August 20, 2026, that it had sent its US customers a warning not to use its supplement-grade glutathione to make injectable drugs.¹ The FDA asked pharmacies that received the powder from Medisca to contact their customers and tell them to stop using the IV product.¹

Why “supplement grade” is the problem

A supplement powder is meant to be swallowed. An IV puts a substance straight into the blood. The FDA said ingredients made for supplements “may contain impurities and contaminants, including endotoxins, that may be harmful when administered as an injectable drug.”¹

The agency said the symptoms people reported are consistent with exposure to too much endotoxin.¹ It added that endotoxin exposure can also cause muscle pain, headache, nausea, vomiting, low blood pressure and death, though not all of those effects have been reported in these glutathione cases.¹ Two Texas pharmacies had recalled glutathione injections because of high endotoxin levels, the FDA said.¹

The FDA placed the responsibility on pharmacies. It said compounders must make sure every ingredient in an injectable drug is suitable for that use, should know their suppliers, and “should not rely on testing alone” to ensure quality.¹ It also asked ingredient suppliers and repackagers to name the original manufacturer on labels and to state clearly what each ingredient may and may not be used for.¹

This is not new territory. The FDA said it first raised concerns about using supplement-grade glutathione in injections in 2019 and “remains concerned about continued risks to patients.”¹ A clinic’s summary of that earlier episode says seven patients had reactions ranging from nausea to trouble breathing, and one needed immediate hospital care.⁴

What has happened since the warning

In late September, NBC News reported that federal health officials had linked dozens of illnesses to possibly contaminated glutathione injections, and that some people had been hospitalized.⁵

A Texas law firm’s summary of a September 2026 CDC update says the CDC had reports of more than 25 people falling ill in at least four states (Texas, Washington, Florida and New York), with at least three hospitalized.² The same summary lists four Texas pharmacy recalls of injectable glutathione so far:²

• Victory Medical Center Pharmacy in Austin, August 5, 2026²
• Optimal Balance Pharmacy in Houston, August 19, 2026²
• Centric Compounding in Houston, September 11, 2026, including products sold as Myers’ Cocktail and Tri-Immune Boost²
• Greenwich Rx in Tomball, October 1, 2026²

The firm notes that the FDA notice does not name the two Texas pharmacies it mentions, and that the Centric Compounding and Greenwich Rx recall notices do not name their glutathione supplier.² So it is not yet clear from these sources whether every recall traces back to the same Medisca batch. The FDA said it is still receiving reports consistent with endotoxin exposure and is actively investigating.¹

What glutathione is, and what the evidence says

Glutathione is an antioxidant the body makes on its own, mostly in the liver, from three amino acids: cysteine, glutamate and glycine.⁶ The body makes less of it with age, and levels can also be lower in people who drink heavily or smoke.⁶ WebMD notes that the FDA has not reviewed glutathione for safety and effectiveness, and that its benefits for any use “are not well defined.”⁶

Fans say it helps fight age-related changes by helping repair damaged tissue and supporting new, healthy cells, and the actor Gwyneth Paltrow is among the celebrities who like it.³ A clinic overview of the research says oral and skin-cream forms have shown only mixed results in small studies, that there are no standard dosing rules for IV glutathione, and that glutathione injections are not FDA-approved as a general detox or anti-aging treatment.⁴

Some scientists are skeptical about the anti-aging case. Andrew Steele, a computational biologist, told the Daily Mail, as quoted by the New York Post:³

“Some research suggests that glutathione supplementation can actually shorten lifespan in worms.”

That remark refers to work in worms, not people, and Steele added that “the science here is interesting.”³

What the warning does not show

The FDA notice is based on reports of illness, not a controlled study. It does not say how many people received drips from the affected batch, so it is not possible to tell from it how often reactions happened. The FDA describes the symptoms as consistent with endotoxin exposure, which is a likely explanation it is still investigating, not a finding confirmed case by case.¹

The warning is also about one specific problem: supplement-grade powder used to make injections. It does not test whether glutathione itself helps or harms, and it says nothing about glutathione taken by mouth. The numbers also differ between sources. The FDA says at least 30 patients,¹ while the CDC figure reported by the law firm is more than 25 people in at least four states.² The two agencies may be counting different sets of cases.

Who is involved, and their interests

The main regulatory document is the FDA’s own notice.¹ The supplier named by the FDA, Medisca, has told the agency it warned customers.¹ Readers should know that the source listing four recalls and the CDC figures is a Texas law firm that has sued Victory Medical Center Pharmacy and is seeking clients who were harmed.² The overview of glutathione research quoted above comes from a primary care and wellness clinic in Florida.⁴

The case fits a wider pattern of FDA alerts about supplement products. In a separate alert updated September 17, 2026, the FDA added three more supplements, sold for weight loss, that it found contained toxic yellow oleander instead of the labeled plant.⁷ Biohack also covered a related policy debate about pharmacy-made injections in US weighs letting pharmacies make unapproved peptide injections.

What to watch next

• Updated case counts. The FDA said it will provide updates as more information comes in.¹
• More recalls. Whether other pharmacies pull glutathione products, and whether recall notices name their supplier.²
• The CDC investigation. Whether it confirms the source of the illnesses across the states involved.²
• Clinic practices. The FDA advised health professionals to ask their compounding pharmacies where their glutathione comes from, and urged anyone with problems to report them through its MedWatch program.¹

This article is news, not medical advice. The FDA says people with concerns should talk to their health care professionals.¹